Pipeline
Despite significant advances in endocrinology, there are still large unmet needs for effective and safe treatments, especially for rare endocrine and related disease. We acknowledge that there is a need for more research and development activities to provide better care for these patients and are building and rapidly advancing a pipeline of innovative peptides.
Therapeutic peptides are particularly well suited as drugs for endocrine diseases, because many hormones are peptides or proteins.
Our portfolio currently includes:
With our team’s established expertise in therapeutic peptides, we aim to further expand and rapidly advance our pipeline of promising innovative peptides through global approval.